Compugen Ltd., a clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe. The company's pipeline consists of COM701, an immuno-oncology pipeline program...
12 insider sale filings on record · latest filing 2026-07-13.
No open-market insider purchases (SEC Form 4 code P) on record for CGEN.